118 related articles for article (PubMed ID: 11714270)
1. Mechanism of the interaction of beta(2)-glycoprotein I with negatively charged phospholipid membranes.
Hammel M; Schwarzenbacher R; Gries A; Kostner GM; Laggner P; Prassl R
Biochemistry; 2001 Nov; 40(47):14173-81. PubMed ID: 11714270
[TBL] [Abstract][Full Text] [Related]
2. Role of the N- and C-terminal domains of bovine beta 2-glycoprotein I in its interaction with cardiolipin.
Hagihara Y; Goto Y; Kato H; Yoshimura T
J Biochem; 1995 Jul; 118(1):129-36. PubMed ID: 8537301
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic fluorescence study of the interaction of human apolipoprotein H with phospholipid vesicles.
Wang SX; Cai Gp; Sui S
Biochemistry; 1999 Jul; 38(29):9477-84. PubMed ID: 10413525
[TBL] [Abstract][Full Text] [Related]
4. Identification of the phospholipid-binding site of human beta(2)-glycoprotein I domain V by heteronuclear magnetic resonance.
Hoshino M; Hagihara Y; Nishii I; Yamazaki T; Kato H; Goto Y
J Mol Biol; 2000 Dec; 304(5):927-39. PubMed ID: 11124037
[TBL] [Abstract][Full Text] [Related]
5. Structure and function of beta 2-glycoprotein I: with special reference to the interaction with phospholipid.
Hagihara Y; Goto Y; Kato H; Yoshimura T
Lupus; 1995 Feb; 4 Suppl 1():S3-5. PubMed ID: 7757108
[TBL] [Abstract][Full Text] [Related]
6. Aggregation of beta(2)-glycoprotein I induced by sodium lauryl sulfate and lysophospholipids.
Hagihara Y; Hong DP; Hoshino M; Enjyoji K; Kato H; Goto Y
Biochemistry; 2002 Jan; 41(3):1020-6. PubMed ID: 11790126
[TBL] [Abstract][Full Text] [Related]
7. [Autoantibodies and thrombosis].
Koike T
Hokkaido Igaku Zasshi; 1997 Sep; 72(5):485-90. PubMed ID: 9363465
[TBL] [Abstract][Full Text] [Related]
8. Proteolytic cleavage of beta(2)-glycoprotein I: reduction of antigenicity and the structural relationship.
Matsuura E; Inagaki J; Kasahara H; Yamamoto D; Atsumi T; Kobayashi K; Kaihara K; Zhao D; Ichikawa K; Tsutsumi A; Yasuda T; Triplett DA; Koike T
Int Immunol; 2000 Aug; 12(8):1183-92. PubMed ID: 10917893
[TBL] [Abstract][Full Text] [Related]
9. Flexible loop of beta 2-glycoprotein I domain V specifically interacts with hydrophobic ligands.
Hong DP; Hagihara Y; Kato H; Goto Y
Biochemistry; 2001 Jul; 40(27):8092-100. PubMed ID: 11434778
[TBL] [Abstract][Full Text] [Related]
10. Solution structure of human and bovine beta(2)-glycoprotein I revealed by small-angle X-ray scattering.
Hammel M; Kriechbaum M; Gries A; Kostner GM; Laggner P; Prassl R
J Mol Biol; 2002 Aug; 321(1):85-97. PubMed ID: 12139935
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome.
Schwarzenbacher R; Zeth K; Diederichs K; Gries A; Kostner GM; Laggner P; Prassl R
EMBO J; 1999 Nov; 18(22):6228-39. PubMed ID: 10562535
[TBL] [Abstract][Full Text] [Related]
12. The fifth domain of beta 2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies.
Hunt J; Krilis S
J Immunol; 1994 Jan; 152(2):653-9. PubMed ID: 7506730
[TBL] [Abstract][Full Text] [Related]
13. Attachment of beta 2-glycoprotein I to negatively charged liposomes may prevent the release of daughter vesicles from the parent membrane.
Urbanija J; Babnik B; Frank M; Tomsic N; Rozman B; Kralj-Iglic V; Iglic A
Eur Biophys J; 2008 Sep; 37(7):1085-95. PubMed ID: 18188552
[TBL] [Abstract][Full Text] [Related]
14. Measurement of antiphospholipid antibody by ELISA using purified beta 2-glycoprotein I in preeclampsia.
Yamamoto T; Yoshimura S; Geshi Y; Sasamori Y; Okinaga S; Kobayashi T; Mori H
Clin Exp Immunol; 1993 Oct; 94(1):196-200. PubMed ID: 8403506
[TBL] [Abstract][Full Text] [Related]
15. Immunization of a rabbit with beta 2-glycoprotein I induces charge-dependent crossreactive antibodies that bind anionic phospholipids and have similar reactivity as autoimmune anti-phospholipid antibodies.
Kouts S; Wang MX; Adelstein S; Krilis SA
J Immunol; 1995 Jul; 155(2):958-66. PubMed ID: 7608571
[TBL] [Abstract][Full Text] [Related]
16. Anti-beta(2)-glycoprotein I antibody-mediated inhibition of activated protein C requires binding of beta(2)-glycoprotein I to phospholipids.
Izumi T; Pound ML; Su Z; Iverson GM; Ortel TL
Thromb Haemost; 2002 Oct; 88(4):620-6. PubMed ID: 12362233
[TBL] [Abstract][Full Text] [Related]
17. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
18. The binding site in {beta}2-glycoprotein I for ApoER2' on platelets is located in domain V.
van Lummel M; Pennings MT; Derksen RH; Urbanus RT; Lutters BC; Kaldenhoven N; de Groot PG
J Biol Chem; 2005 Nov; 280(44):36729-36. PubMed ID: 16091370
[TBL] [Abstract][Full Text] [Related]
19. Characterization of binding of human beta 2-glycoprotein I to cardiolipin.
Kertesz Z; Yu BB; Steinkasserer A; Haupt H; Benham A; Sim RB
Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):315-21. PubMed ID: 7646462
[TBL] [Abstract][Full Text] [Related]
20. Characterization of beta2-glycoprotein I binding to phospholipid membranes.
Harper MF; Hayes PM; Lentz BR; Roubey RA
Thromb Haemost; 1998 Oct; 80(4):610-4. PubMed ID: 9798980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
